Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.74 +0.01 (+0.14%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Shares Outstanding (Entity) (2024 - 2025)

Drugs Made In America Acquisition (DMAA) Shares Outstanding (Entity) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 56.93 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 51.75 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 50.00 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 45.00 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 35.94 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 36.74 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 37.50 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 36.11 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 32.92 Mn
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 20.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 21.01 Mn
Sep 30, 2025 23.00 Mn
Jun 30, 2025 23.00 Mn
Mar 31, 2025 15.18 Mn
Dec 31, 2024 9.86 Mn